Skip to main content

Table 2 Comparison of MHR, hematology parameters and tumor markers between CRC patients and healthy controls

From: Predictive value of monocyte to high-density lipoprotein cholesterol ratio and tumor markers in colorectal cancer and their relationship with clinicopathological characteristics

Indicators

Colorectal cancer

Controls

F

P

N

202

201

  

Age

60.65 ± 12.23

59.37 ± 7.67

45.57

0.210

ALT

20.20 ± 15.47

23.72 ± 12.98

0.23

0.014

AST

26.83 ± 15.24

24.86 ± 8.12

10.12

0.106

Total protein

68.22 ± 8.41

72.87 ± 4.88

29.14

 < 0.001

Total cholesterol

4.81 ± 1.04

4.44 ± 0.69

1053

 < 0.001

Triglyceride

1.56 ± 1.25

1.13 ± 0.36

44.53

 < 0.001

Monocyte count

0.64 ± 0.30

0.42 ± 0.10

28.50

 < 0.001

HDL-C

1.17 ± 0.31

1.32 ± 0.20

29.87

 < 0.001

LDL-C

3.01 ± 0.86

2.91 ± 0.17

147.74

0.081

CA153

10.79 ± 6.64

11.08 ± 5.77

43.58

0.637

MHR

0.58 ± 0.29

0.33 ± 0.10

61.48

 < 0.001

CEA

3.78 (0.50–160.25)

2.12 (0.50–12.39)

65.27

 < 0.001

CA199

10.85 (0.00–693.55)

6.60 (2.00–38.46)

77.29

 < 0.001

CA125

10.05 (2.90–203.50)

10.50 (2.50–41.50)

43.58

0.502

  1. The P value was calculated by Independent-Samples T-test/ Mann–Whitney U-test
  2. ALT alanine aminotransferase, AST aspartate aminotransferase, CA125 carbohydrate antigen 125, CA153 carbohydrate antigen 153, CA199 carbohydrate antigen 199, CEA carcinoembryonic antigen, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, MHR monocytes to high-density lipoprotein cholesterol ratio